Catalyst Wire Dossier Catalyst Wire Dossier

Anti-CD19 CAR T cells

CD19-directed CAR T cells
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Anti-CD19 CAR T cells, covering 2019-12-12 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases [Phase 1, Phase 2]

See pricing